Fleta Bray is a Dermatology physician affiliated with University of Miami. OpenAlex indexes 43 publications with 749 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 NW 10th Ave # 2023a
Miami, FL 331361015
Telephone
305-243-4472Provider last certified this registry record 26 Oct 2021.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Resmed CorpProgram year20251 payment
- UCB, Inc.Program year20242 payments
- Janssen Biotech, Inc.Program year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
33.7%Corticosteroid13.2%Triamcinolone Acetonide78%Triamcinolone acetonide22%Part D + Part B≥38 patientsalpha-Hydroxy Acid8.1%Ammonium Lactate100%Part D≥23 patients+ 3 more classes in this area
Anti-infectives
30.6%Azole Antifungal22.1%Ketoconazole100%Part D≥57 patientsLincosamide Antibacterial5.8%Clindamycin Phosphate100%Part D≥11 patients+ 1 more class in this area
Cancer & immunology
10.4%Phosphodiesterase 4 Inhibitor4.4%Otezla100%Part D<11 patientsCalcineurin inhibitor3.9%Tacrolimus100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Association of polycystic ovary syndrome with atopic dermatitis: a case control study
Archives of Dermatological Research
2024 - 253 Association of polycystic ovary syndrome with atopic dermatitis: a cross-sectional study
Journal of Investigative Dermatology
2024 - Access to dermatologic care in Indigenous American communities
Journal of the American Academy of Dermatology
2022 - Evaluation of synthetic alpha-melanocyte-stimulating hormone analogs: An observational study of unregulated, online-available drugs
Journal of the American Academy of Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”